0001947723-24-000001.txt : 20240308 0001947723-24-000001.hdr.sgml : 20240308 20240308101833 ACCESSION NUMBER: 0001947723-24-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240308 DATE AS OF CHANGE: 20240308 EFFECTIVENESS DATE: 20240308 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Curavit Clinical Research Corp CENTRAL INDEX KEY: 0001947723 ORGANIZATION NAME: IRS NUMBER: 844218254 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-461679 FILM NUMBER: 24732712 BUSINESS ADDRESS: STREET 1: 18 LARCH LANE CITY: SCARSDALE STATE: NY ZIP: 10583 BUSINESS PHONE: 917-885-0024 MAIL ADDRESS: STREET 1: 18 LARCH LANE CITY: SCARSDALE STATE: NY ZIP: 10583 D/A 1 primary_doc.xml X0708 D/A LIVE 0001947723 Curavit Clinical Research Corp 18 LARCH LANE SCARSDALE NY NEW YORK 10583 917-885-0024 DELAWARE None None Corporation true 2019 Joel Morse c/o Curavit Clinical Research Corp 18 Larch Lane Scarsdale NY NEW YORK 10583 Executive Officer Director David Hanaman c/o Curavit Clinical Research Corp 18 Larch Lane Scarsdale NY NEW YORK 10583 Director Nathanael Lentz c/o Curavit Clinical Research Corp 18 Larch Lane Scarsdale NY NEW YORK 10583 Director Rich Lester c/o Curavit Clinical Research Corp 18 Larch Lane Scarsdale NY NEW YORK 10583 Director Jackie Kent c/o Curavit Clinical Research Corp 18 Larch Lane Scarsdale NY NEW YORK 10583 Director Other Health Care Decline to Disclose 06b true 0001947723-22-000001 2022-09-28 true true true true false 0 10393329 10116574 276755 false 30 0 0 0 false Curavit Clinical Research Corp /s/ Joel Morse Joel Morse Chief Executive Officer 2024-03-08